Up-to-date, the total revenue is around 7.8 B, compared with mrna's 7.0B, the SP is totally unfair for BNTX and it is well under-valued. The cash flow will look fantastic eventually. This company needs to hire a top notch chief marketing officer not only for itself but also for investors. The flu+mrna vaccines, cancer vaccines, and many others will make its day in the long run!$BioNTech SE(BNTX)$
精彩评论